famotidine has been researched along with Lung Neoplasms in 7 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Lung Neoplasms: Tumors or cancer of the LUNG.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Famotidine may enhance the activity of T-cells further by allowing for increased IL-2 internalization by the IL-2 receptor on lymphocytes." | 5.36 | Pulse infusion interleukin-2 with famotidine and cyclophosphamide has activity in previously treated metastatic melanoma. ( Knupp, C; Quan, F; Quan, W; Walker, P, 2010) |
| "Famotidine may increase IL-2 internalization by the IL-2 receptor on T-lymphocytes." | 5.35 | Low-dose cyclophosphamide and continuous-infusion interleukin-2 with famotidine in previously treated metastatic melanoma or kidney cancer. ( King, LA; Quan, FM; Quan, WD; Walker, PR, 2008) |
| "Famotidine may enhance the lysis of tumors by cytotoxic lymphocytes." | 5.32 | High-dose continuous infusion plus pulse interleukin-2 and famotidine in melanoma. ( Jackson, S; Khan, N; Quan, W; Ramirez, M; Taylor, WC; Vinogradov, M, 2004) |
| "Famotidine may enhance the activity of T-cells further by allowing for increased IL-2 internalization by the IL-2 receptor on lymphocytes." | 1.36 | Pulse infusion interleukin-2 with famotidine and cyclophosphamide has activity in previously treated metastatic melanoma. ( Knupp, C; Quan, F; Quan, W; Walker, P, 2010) |
| "Famotidine may increase IL-2 internalization by the IL-2 receptor on T-lymphocytes." | 1.35 | Low-dose cyclophosphamide and continuous-infusion interleukin-2 with famotidine in previously treated metastatic melanoma or kidney cancer. ( King, LA; Quan, FM; Quan, WD; Walker, PR, 2008) |
| "Famotidine may enhance the lysis of tumors by cytotoxic lymphocytes." | 1.32 | High-dose continuous infusion plus pulse interleukin-2 and famotidine in melanoma. ( Jackson, S; Khan, N; Quan, W; Ramirez, M; Taylor, WC; Vinogradov, M, 2004) |
| "tumor growth, secondary lung metastasis and splenocyte cytotoxicity against YAC-1 lymphoma cells (51Cr release assay)." | 1.29 | Effects of histamine type-2 receptor antagonists on indomethacin and IL-2 immunotherapy of metastasis. ( Khoo, NK; Lala, PK; Saarloos, MN, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Quan, W | 3 |
| Knupp, C | 1 |
| Quan, F | 2 |
| Walker, P | 2 |
| Ramirez, M | 2 |
| Taylor, WC | 1 |
| Vinogradov, M | 2 |
| Khan, N | 1 |
| Jackson, S | 1 |
| Taylor, C | 1 |
| Quan, WD | 1 |
| Quan, FM | 1 |
| King, LA | 1 |
| Walker, PR | 1 |
| Mori, K | 1 |
| Tominaga, K | 1 |
| Yokoyama, K | 1 |
| Suga, Y | 1 |
| Kishiro, I | 1 |
| Tsurui, M | 1 |
| Saarloos, MN | 1 |
| Khoo, NK | 1 |
| Lala, PK | 1 |
| Sartori, S | 1 |
| Nielsen, I | 1 |
| Maestri, A | 1 |
| Beltrami, D | 1 |
| Trevisani, L | 1 |
| Pazzi, P | 1 |
2 trials available for famotidine and Lung Neoplasms
| Article | Year |
|---|---|
Administration of high-dose continuous infusion interleukin-2 to patients age 70 or over.
Topics: Adenosine; Aged; Aged, 80 and over; Aging; Capillary Leak Syndrome; Famotidine; Hemodynamics; Humans | 2005 |
Efficacy of famotidine in patients with acute gastric mucosal injury after continuous infusion of cisplatin plus vindesine.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Flow Velocity; Carcinoma, Non-Sma | 1995 |
5 other studies available for famotidine and Lung Neoplasms
| Article | Year |
|---|---|
Pulse infusion interleukin-2 with famotidine and cyclophosphamide has activity in previously treated metastatic melanoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cycl | 2010 |
High-dose continuous infusion plus pulse interleukin-2 and famotidine in melanoma.
Topics: Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Drug Therapy, Combination; Famotidine; Female; H | 2004 |
Low-dose cyclophosphamide and continuous-infusion interleukin-2 with famotidine in previously treated metastatic melanoma or kidney cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Renal Cell; Cycloph | 2008 |
Effects of histamine type-2 receptor antagonists on indomethacin and IL-2 immunotherapy of metastasis.
Topics: Adenocarcinoma; Adjuvants, Immunologic; Animals; Cimetidine; Famotidine; Female; Histamine H2 Antago | 1993 |
Acute gastroduodenal mucosal injury after cisplatin plus etoposide chemotherapy. Clinical and endoscopic study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Endoscopy; Etoposide; Famotidine; | 1991 |